What is ABSCI CORPORATION share price today?

ABSCI CORPORATION (ABSI) share price today is {{live_price}}.

Can Indians buy ABSCI CORPORATION shares?

Yes, Indians can invest in the ABSCI CORPORATION (ABSI) from India. With INDmoney, you can buy ABSCI CORPORATION at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy ABSCI CORPORATION at zero transaction cost.

How can I buy ABSCI CORPORATION shares from India?

It is very easy to buy ABSCI CORPORATION from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of ABSCI CORPORATION be purchased?

Yes, you can buy fractional shares of ABSCI CORPORATION with INDmoney app.

What are the documents required to start investing in ABSCI CORPORATION stocks?

To start investing in ABSCI CORPORATION, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of ABSCI CORPORATION

Today’s highest price of ABSCI CORPORATION (ABSI) is {{1_rba_end}}. Today’s lowest price of ABSCI CORPORATION (ABSI) is {{1_rba_st}}.

What is today's market capitalisation of ABSCI CORPORATION

Today's market capitalisation of ABSCI CORPORATION ABSI is 158.2M

What is the 52 Week High and Low Range of ABSCI CORPORATION

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage ABSCI CORPORATION is down from its 52 Week High?

ABSCI CORPORATION (ABSI) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage ABSCI CORPORATION is up from its 52 Week low?

ABSCI CORPORATION (ABSI) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of ABSCI CORPORATION?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of ABSCI CORPORATION

Mr. Sean McClain is the current Chief Executive Officer (CEO) of ABSCI CORPORATION.

Home

US Stocks

ABSCI CORPORATION

ABSCI CORPORATION (ABSI)

$1.71

+0.1

(+6.21%)▲

Market is closed - opens 7 PM, 30 May 2023

Insights on ABSCI CORPORATION

Decreasing Revenue
Revenue is down for the last 2 quarters, 3.37M → 1.26M (in $), with an average decrease of 62.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -77.64M → -23.34M (in $), with an average increase of 232.7% per quarter
Vs SGEN
In the last 1 year, Seagen Inc has given 36.8% return, outperforming this stock by 93.5%

Performance

$1.60
$1.77
$1.71
6.43%
Downside
Day's Volatility :9.6%
Upside
3.39%
$1.13
$7.04
$1.71
33.92%
Downside
52 Weeks Volatility :83.95%
Upside
75.71%

Returns

Period	ABSCI CORPORATION	Sector (Health Care)	Index (Russel 2000)
3 Months	-20.99%	0.3%	-6.7%
6 Months	-26.7%	-6.1%	-3.7%
1 Year	-54.11%	-4.8%	-6.3%
3 Years	-92.24%	23.8%	26.9%

Highlights

Market Capitalization	158.2M
Book Value	$2.75
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	-1.04
Wall Street Target Price	7.73

Profit Margin	0.0%
Operating Margin TTM	-1640.83%

Return On Assets TTM	-18.39%
Return On Equity TTM	-33.23%

Revenue TTM	6.2M
Revenue Per Share TTM	0.07
Quarterly Revenue Growth YOY	54.900000000000006%
Gross Profit TTM	-39.8M
EBITDA	-88.0M
Diluted Eps TTM	-1.04
Quarterly Earnings Growth YOY	0.0

EPS Estimate Current Year	-0.95
EPS Estimate Next Year	-0.71
EPS Estimate Current Quarter	-0.24
EPS Estimate Next Quarter	-0.23

Analyst Recommendation

Buy

69%Buy

15%Hold

15%Sell

Based on 13 Wall street analysts offering stock ratings for ABSCI CORPORATION(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 352.05%

Current $1.71

Target $7.73

Company Financials

	FY19	Y/Y Change
Revenue	2.1M	-
Net Income	-6.6M	-
Net Profit Margin	-319.61%	-

	FY20	Y/Y Change
Revenue	4.8M	↑ 132.04%
Net Income	-14.4M	↑ 118.0%
Net Profit Margin	-300.27%	↑ 19.34%

	FY21	Y/Y Change
Revenue	4.8M	↑ 0.04%
Net Income	-101.0M	↑ 603.41%
Net Profit Margin	-2.1K%	↓ 1810.98%

	FY22	Y/Y Change
Revenue	5.7M	↑ 20.18%
Net Income	-104.9M	↑ 3.91%
Net Profit Margin	-1.8K%	↑ 285.88%

	Q4 FY21	Q/Q Change
Revenue	-815.0K	↓ 152.96%
Net Income	-25.2M	↑ 6.48%
Net Profit Margin	3.1K%	↑ 4623.52%

	Q1 FY22	Q/Q Change
Revenue	819.0K	↓ 200.49%
Net Income	-29.5M	↑ 17.2%
Net Profit Margin	-3.6K%	↓ 6689.07%

	Q2 FY22	Q/Q Change
Revenue	1.0M	↑ 22.34%
Net Income	-28.7M	↓ 2.76%
Net Profit Margin	-2.9K%	↑ 738.94%

	Q3 FY22	Q/Q Change
Revenue	2.4M	↑ 136.43%
Net Income	-27.3M	↓ 4.95%
Net Profit Margin	-1.2K%	↑ 1711.63%

	Q4 FY22	Q/Q Change
Revenue	3.4M	↑ 42.59%
Net Income	-77.6M	↑ 184.84%
Net Profit Margin	-2.3K%	↓ 1147.9%

	Q1 FY23	Q/Q Change
Revenue	1.3M	↓ 62.43%
Net Income	-23.3M	↓ 69.94%
Net Profit Margin	-1.8K%	↑ 459.23%

	FY19	Y/Y Change
Total Assets	19.5M	-
Total Liabilities	60.6M	-

	FY20	Y/Y Change
Total Assets	88.6M	↑ 354.88%
Total Liabilities	178.0M	↑ 193.58%

	FY21	Y/Y Change
Total Assets	426.2M	↑ 381.2%
Total Liabilities	60.1M	↓ 66.24%

	FY22	Y/Y Change
Total Assets	321.0M	↓ 24.68%
Total Liabilities	46.6M	↓ 22.46%

	Q4 FY21	Q/Q Change
Total Assets	426.2M	↓ 5.1%
Total Liabilities	60.1M	↓ 1.67%

	Q1 FY22	Q/Q Change
Total Assets	395.5M	↓ 7.21%
Total Liabilities	55.0M	↓ 8.53%

	Q2 FY22	Q/Q Change
Total Assets	366.3M	↓ 7.37%
Total Liabilities	50.1M	↓ 8.81%

	Q3 FY22	Q/Q Change
Total Assets	339.4M	↓ 7.35%
Total Liabilities	46.4M	↓ 7.34%

	Q4 FY22	Q/Q Change
Total Assets	321.0M	↓ 5.42%
Total Liabilities	46.6M	↑ 0.32%

	Q1 FY23	Q/Q Change
Total Assets	295.8M	↓ 7.85%
Total Liabilities	41.8M	↓ 10.2%

	FY19	Y/Y Change
Operating Cash Flow	-6.0M	-
Investing Cash Flow	-1.1M	-
Financing Cash Flow	12.7M	-

	FY20	Y/Y Change
Operating Cash Flow	-11.0M	↑ 81.86%
Investing Cash Flow	-2.2M	↑ 99.36%
Financing Cash Flow	71.0M	↑ 458.58%

	FY21	Y/Y Change
Operating Cash Flow	-60.6M	↑ 452.4%
Investing Cash Flow	-67.4M	↑ 3003.5%
Financing Cash Flow	336.2M	↑ 373.69%

	Q4 FY21	Q/Q Change
Operating Cash Flow	-17.1M	↓ 21.47%
Investing Cash Flow	-8.3M	↑ 21.94%
Financing Cash Flow	-1.3M	↓ 100.62%

	Q1 FY22	Q/Q Change
Operating Cash Flow	-21.1M	↑ 23.83%
Investing Cash Flow	-6.9M	↓ 17.54%
Financing Cash Flow	-1.1M	↓ 18.36%

	Q2 FY22	Q/Q Change
Operating Cash Flow	-22.6M	↑ 6.76%
Investing Cash Flow	-11.2M	↑ 63.67%
Financing Cash Flow	5.8M	↓ 650.38%

	Q3 FY22	Q/Q Change
Operating Cash Flow	-19.0M	↓ 15.66%
Investing Cash Flow	-78.7M	↑ 601.44%
Financing Cash Flow	-921.0K	↓ 115.82%

Technicals Summary

Sell

Neutral

Buy

ABSCI CORPORATION is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
ABSCI CORPORATION	34.0%	-26.7%	-54.11%	-92.24%	-92.24%
Moderna, Inc.	-5.37%	-27.09%	-13.14%	105.27%	578.71%
Regeneron Pharmaceuticals, Inc.	-10.19%	-1.57%	8.99%	18.23%	144.36%
Seagen, Inc.	-2.85%	64.85%	42.61%	23.08%	248.38%
Vertex Pharmaceuticals Incorporated	-4.35%	4.32%	22.83%	14.6%	112.57%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	BVPS
ABSCI CORPORATION	NA	NA	NA	-0.95	-0.33	-0.18	2.75
Moderna, Inc.	11.28	11.28	0.0	-1.96	0.27	0.12	49.12
Regeneron Pharmaceuticals, Inc.	20.02	20.02	9.01	41.59	0.19	0.1	219.38
Seagen, Inc.	NA	NA	18.53	-2.88	-0.23	-0.12	14.54
Vertex Pharmaceuticals Incorporated	27.02	27.02	0.41	14.64	0.26	0.17	56.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
ABSCI CORPORATION	Buy	$158.2M	-92.24%	NA	0.0%
Moderna, Inc.	Buy	$48.2B	578.71%	11.28	31.77%
Regeneron Pharmaceuticals, Inc.	Buy	$79.5B	144.36%	20.02	33.81%
Seagen, Inc.	Hold	$36.5B	248.38%	NA	-31.55%
Vertex Pharmaceuticals Incorporated	Buy	$85.7B	112.57%	27.02	35.4%

Institutional Holdings

FMR Inc
14.98%
Redmile Group, LLC
8.68%
Casdin Capital, LLC
7.96%
BlackRock Inc
4.33%
Vanguard Group Inc
2.63%
State Street Corporation
1.22%

Corporate Announcements

ABSCI CORPORATION Earnings
ABSCI CORPORATION’s price-to-earnings ratio stands at None
Read More

ABSCI CORPORATION (ABSI)

Insights on ABSCI CORPORATION

Decreasing Revenue

Increasing Net Profit

Vs SGEN